🇺🇸
United States · US · US:0078-0937_59dff6dc-c0b0-4f26-9738-32f8a6540033
EGATEN
Orange BookUNIISPLATC P02BX04
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerNovartis Pharmaceuticals Corporation
CountryUS (United States)
ATC codeP02BX04
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1100780937914 TABLET in 1 BLISTER PACK (0078-0937-91)
Annotations
UNII (FDA Substance ID)
4784C8E03O
TRICLABENDAZOLE
RxCUI 2118525
Orange Book
N208711
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "4784C8E03O",
"rxcui": "2118525",
"inchikey": "NQPDXQQQCQDHHW-UHFFFAOYSA-N",
"display_name": "TRICLABENDAZOLE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"spl_meta": {
"5552884e-10ea-450c-9658-d3d4f33c946e": {
"match": "brand_token",
"title": "EGATEN (TRICLABENDAZOLE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION]",
"spl_version": "11",
"published_date": "2025-03-10"
}
},
"productid": "0078-0937_59dff6dc-c0b0-4f26-9738-32f8a6540033",
"productndc": "0078-0937",
"dosage_form": "TABLET",
"orange_book": {
"appl_no": "208711",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "250MG",
"product_no": "001",
"approval_date": "Feb 13, 2019"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "TRICLABENDAZOLE",
"proprietary_name": "EGATEN",
"active_ingred_unit": "mg/1",
"application_number": "NDA208711",
"marketing_category": "NDA",
"nonproprietary_name": "triclabendazole",
"start_marketing_date": "20190213",
"active_numerator_strength": "250"
}Related drugs
Other records sharing ATC code P02BX04.
Access this data programmatically
Query EGATEN and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.